Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

METABASIS THERAPEUTICS INC (MBRX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $3.62 Metrics
OS: 35.2 M -434 % ROE
Market cap: $127 M
Net cash: $2.18 M $0.06 per share
EV: $125 M

 
TTM Valuation
EBITDA
EBIT ($11.7) M
EPS ($1.32)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02Dec-31-01
Revenues4.89.04.43.86.89.12.37.7
            Revenue growth-46.7%105.6%16.3%-44.8%-25.1%300.5%-70.3%109.8%
Cost of goods sold0.00.00.00.00.00.00.00.0
Gross profit4.89.04.43.86.89.12.37.7
            Gross margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
General and administrative10.812.411.37.24.93.02.52.1
EBIT-42.3-44.3-36.8-24.7-15.3-9.8-13.5-4.6
            EBIT margin-879.4%-491.6%-839.2%-654.1%-223.4%-107.7%-591.1%-59.4%
Pre-tax income-42.3-41.8-33.3-23.6-15.0-9.4-12.8-3.7
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-42.3-41.8-33.3-23.6-15.0-9.4-12.8-3.7
            Net margin-879.7%-463.5%-758.5%-625.3%-219.0%-103.3%-561.8%-48.0%
 
Diluted EPS($1.25)($1.37)($1.15)($1.20)($1.49)($6,547.92)($10.12)($4.44)
Shares outstanding (diluted)33.830.629.019.710.00.01.30.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy